Skip to application
All calculators and tools

Preparation. Administration. Evidence.

IV Dilution &
Medication Reference

Search 255 medications, read preserved historical references, and inspect separately reviewed preparation statements. Full monograph updates remain pending.

Version 6.4Release date 2026-11-04For healthcare professionals
Back to resultsA-Z list

Medication reference

Fentanyl

Monograph awaiting updateThis monograph will be updated in the future.

Jump to a section

Historical source. Current clinical review is incomplete. This monograph will be updated in the future.

Fentanyl (opens in a new tab)Original source URL: https://globalrph.com/dilution/fentanyl/ | Retrieved 2026-11-04

Source dates, location and integrity

This historical article is separate from the reviewed claim cards. Product formulations and source dates may differ.

Original source URL
https://globalrph.com/dilution/fentanyl/ (opens in a new tab)
Source date
Not established in the retrieved source
Retrieved
2026-11-04T19:46:47.266245+00:00
Source location
div.post-content
Packaged content SHA-256
a2022b1a2af084d95bd3744e045aee85f5999d5b3e7e758e0a40bc651e595caf
Original response SHA-256
f074a3ecc96332911677b6b92cb3b3abf422b0e017e3a45ad96058cd766dbd22
Source body SHA-256
5df4a1eed79781e63eb5f6e6101cb70a0fc6855a449bbc0ac1e4a90444527eba

FENTANYL

The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER CAREFULLY BEFORE ACCESSING OR USING THIS SITE. BY ACCESSING OR USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS SET FORTH IN THE DISCLAIMER.

Usual Diluents

NS, D5W

Standard Dilutions [Amount of drug] [Infusion volume] [Infusion rate]

[0 - 5000 mcg] [50-250ml] [Titrate]
[1250 mcg] [250 ml] [Titrate]
[2500 mcg] [250 ml] [Titrate]
[5000 mcg] [250 ml] [Titrate]

(May concentrate further)
[2500 mcg] [ 50 ml] (50 mcg/ml)

Stability / Miscellaneous

Stability data:

Drug Stability
Refrigerated
Stability
Room Temp.
Reconstituted
Vial/Powder
Notes
Fentanyl Protect from light. Retain in carton until time of use.
Store at 20 to 25°C (68 to 77°F)
Solution Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.
Do not administer unless solution is clear and container undamaged. Discard unused portion.


EXP
: 2 Days (RT / REF).
Some studies indicate stability up to 30 days.

Minimum dilution: 2500 to 5000 mcg/ 50 ml.
--------------------------------------------------------------------------------

Adults:
Premedication: I.M., slow I.V.: 50-100 mcg/dose 30-60 minutes prior to surgery

Adjunct to regional anesthesia: I.M., slow I.V.: 50-100 mcg/dose; if I.V. used, give over 1-2 minutes

Severe pain: I.M.: 50-100 mcg/dose every 1-2 hours as needed; patients with prior opiate exposure may tolerate higher initial doses

Adjunct to general anesthesia: Slow I.V.:
Low dose: Initial: 2 mcg/kg/dose; Maintenance: Additional doses infrequently needed
Moderate dose: Initial: 2-20 mcg/kg/dose; Maintenance: 25-100 mcg/dose may be given slow I.V. or I.M. as needed

High dose: Initial: 20-50 mcg/kg/dose; Maintenance: 25 mcg to one-half the initial loading dose may be given as needed

General anesthesia without additional anesthetic agents: Slow I.V.: 50-100 mcg/kg with O2 and skeletal muscle relaxant

Mechanically-ventilated patients (based on 70 kg patient): Slow I.V.: 0.35-1.5 mcg/kg every 30-60 minutes as needed; infusion: 0.7 - 10 mcg/kg/hour

Patient-controlled analgesia (PCA): I.V.: Usual concentration: 50 mcg/mL
Demand dose: Usual: 10 mcg; range: 10-50 mcg
Lockout interval: 5-8 minutes

--------------------------------------------------------------------------------

DOSAGE AND ADMINISTRATION
50 mcg = 0.05 mg = 1 mL

Dosage should be individualized. Some of the factors to be considered in determining the dose are age, body weight, physical status, underlying pathological condition, use of other drugs, type of anesthesia to be used and the surgical procedure involved. Dosage should be reduced in elderly or debilitated patients.

Vital signs should be monitored routinely.

I.Premedication- Premedication (to be appropriately modified in the elderly, debilitated, and those who have received other depressant drugs)-50 mcg to 100 mcg (0.05 mg to 0.1 mg) (1 mL to 2 mL) may be administered intramuscularly 30 to 60 minutes prior to surgery.

II.Adjunct to General Anesthesia- See Dosage Range Chart

III.Adjunct to Regional Anesthesia- 50 mcg to 100 mcg (0.05 mg to 0.1 mg) (1 mL to 2 mL) may be administered intramuscularly or slowly intravenously, over one to two minutes, when additional analgesia is required.

IV.Postoperatively (recovery room)- 50 mcg to 100 mcg (0.05 mg to 0.1 mg) (1 mL to 2 mL) may be administered intramuscularly for the control of pain, tachypnea, and emergence delirium. The dose may be repeated in one to two hours as needed.

Usage in Children: For induction and maintenance in children 2 to 12 years of age, a reduced dose as low as 2 mcg/kg to 3 mcg/kg is recommended.

DOSAGE RANGE CHART

TOTAL DOSAGE (expressed as fentanyl base)
Low Dose - Moderate Dose - High Dose -
2 mcg/kg (0.002 mg/kg) (0.04 mL/kg) Fentanyl, in small doses is most useful for minor, but painful, surgical procedures. In addition to the analgesia during surgery, Fentanyl may also provide some pain relief in the immediate postoperative period. 2-20 mcg/kg (0.002-0.02 mg/kg) (0.04-0.4 mL/kg) Where surgery becomes more major, a larger dose is required. With this dose, in addition to adequate analgesia, one would expect to see some abolition of the stress response. However, respiratory depression will be such that artificial ventilation during anesthesia is necessary and careful observation of ventilation postoperatively is essential. 20-50 mcg/kg (0.02-0.05 mg/kg) (0.4-1 mL/kg) During open heart surgery and certain more complicated neurosurgical and orthopedic procedures where surgery is more prolonged, and in the opinion of the anesthesiologist, the stress response to surgery would be detrimental to the well being of the patient, dosages of 20-50 mcg/kg (0.02-0.05 mg/kg) (0.4-1 mL/kg) of fentanyl with nitrous oxide/oxygen have been shown to attenuate the stress response as defined by increased levels of circulating growth hormone, catecholamine, ADH, and prolactin. When dosages in this range have been used during surgery, postoperative ventilation and observation are essential due to extended postoperative respiratory depression. The main objective of this technique would be to produce"stress-free" anesthesia.
DOSAGE RANGE CHART
MAINTENANCE DOSAGE (expressed as fentanyl base)
Low Dose - Moderate Dose - High Dose -
2 mcg/kg (0.002 mg/kg) (0.04 mL/kg) Additional dosages of fentanyl are infrequently needed in these minor procedures. 2-20 mcg/kg (0.002-0.02 mg/kg) (0.04-0.4 mL/kg) 25-100 mcg (0.025 to 0.1 mg) (0.5 to 2 mL) may be administered intravenously or intramuscularly when movement and/or changes in vital signs indicate surgical stress or lightening of analgesia. 20-50 mcg/kg (0.02-0.05 mg/kg) (0.4-1.0 mL/kg) Maintenance dosage (ranging from 25 mcg (0.025 mg) (0.5 mL) to one half the initial loading dose) will be dictated by the changes in vital signs which indicate stress and lightening of analgesia. However, the additional dosage selected must be individualized especially if the anticipated remaining operative time is short.

As a General Anesthetic:
When attenuation of the responses to surgical stress is especially important, doses of 50 mcg/kg to 100 mcg/kg (0.05 mg/kg to 0.1 mg/kg) (1 mL/kg to 2 mL/kg) may be administered with oxygen and a muscle relaxant. This technique has been reported to provide anesthesia without the use of additional anesthetic agents. In certain cases, doses up to 150 mcg/kg (0.15 mg/kg) (3 mL/kg) may be necessary to produce this anesthetic effect. It has been used for open heart surgery and certain other major surgical procedures in patients for whom protection of the myocardium from excess oxygen demand is particularly indicated, and for certain complicated neurological and orthopedic procedures.

As noted above, it is essential that qualified personnel and adequate facilities be available for the management of respiratory depression.

See package insert for WARNINGS and PRECAUTIONS for use of fentanyl with other CNS depressants, and in patients with altered response.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

HOW SUPPLIED
Fentanyl Citrate Injection, USP equivalent to 50 mcg (0.05 mg) fentanyl/mL, is supplied in single-dose glass containers as follows:

Size Container Package Package Size List No.
2 mL Ampul ten's 9093
2 mL Fliptop Vial twenty five's 9094
5 mL Ampul ten's 9093
5 mL Fliptop Vial twenty five's 9094
10 mL Ampul five's 9093
10 mL Fliptop Vial one's 9094
20 mL Ampul five's 9093
20 mL Fliptop Vial one's 9094
50 mL Fliptop Vial one's 9094

PROTECT FROM LIGHT. Store at 20 to 25°C (68 to 77°F). [See USP Controlled Room Temperature.]

Revised: April, 2007
Printed in USA EN-1504
Hospira, Inc., Lake Forest, IL 60045 USA

Source: [package insert]

Additional Pain Management / Palliative Care resources

Drug Tables and Calculators

---Medical Articles / News / Other---

How does pregabalin compare to gabapentin in the treatment of neuropathic pain?
Pain Management: Its various aspects

Open this historical article on its own

Product identifiers and clinical review status

This monograph will be updated in the future. Historical material is available where present in the original sources; full current exact-product and claim-level review remains pending.

Exact formulation, concentration, container, manufacturer, regulatory identifiers, and a reproducible label snapshot have not all been reconciled.

What remains to be completed
  • Retrievable exact-product SPL XML with version, revision, retrieval date and reproducible hash
  • Clinically reviewed, individually identified statements with two exact source mappings
  • Exact formulation, strength, container, manufacturer/labeler, application and NDC reconciliation
  • Renal-function methods and dialysis/CRRT modality review where applicable
  • Mechanism provenance, clinical source disagreements and full medication-specific safety reconciliation

Supplemental historical fields

Restored-data provenance and review notes

Source release: 2026-08-31. Current clinical review is incomplete. Original uses of current, verified, or normalized describe the historical source. They do not inherit the status of separately reviewed statements. Product formulations and source dates can differ.

Current review annotations for historical renal, dialysis, mechanism, and product fieldsSeparate renal reference: Open Renal Dosing Master (opens in a new tab)
Renal
Status
not_locally_normalized
Original classification
current_label_review_required
Entries
    General note
    Preserve the source-specific renal-function basis. An indexed CrCl table is not interchangeable with unindexed CrCl or eGFR. Generic advice to check a method does not identify the equation for a dose row.
    Dialysis
    Status
    no_local_structured_regimen
    Entries
      General note
      Named modality alone does not establish applicability. CRRT subtype, effluent rate, residual renal function, timing and interruptions require review. Historical absence is not evidence that no guidance exists.
      Mechanisms
      • Source kind
        first_look
        Local pointer
        /mechanism
        Original level
        drug_specific
        Provenance classification
        historical_drug_specific_uncorroborated
        Label derived verified
        false
        Independently corroborated
        false
        Exact label section
        Not recorded
        Original source note
        Not recorded
        Review status
        historical_unverified
        Note
        Drug-specific wording in the old file is not proof of independent corroboration or an exact label locator. Consult separately published current mechanism claims where present.
      Future update
      Status
      pending_review
      Message
      This monograph will be updated in the future as current exact-product and claim-level review is completed.
      Source unavailable
      false
      Reason
      The historical content is restored; comprehensive contemporary verification remains incomplete.
      Historical first look: uses, mechanism, dosing context, and administration

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      fentanyl
      Source IDH51-08BE96338526854050BF8B28
      Generic name
      Fentanyl
      Source IDH51-F0D97DD6C1BA088AAF200374
      Class
      Sedation, analgesia, and anesthesia
      Source IDH51-EF8EAF853F9DBA93E8955EA3
      Subclass
      Opioid analgesic
      Source IDH51-3704C0A9C88CAFEFF4EBD05A
      Primary uses
      1. Severe pain
        Source IDH51-32F3E74C18374975E003C7C7
      2. Procedural analgesia
        Source IDH51-3713D5147108F1637C6741BC
      3. ICU analgesia and sedation
        Source IDH51-D35A001A04C277A76CDC21E0
      Mechanism
      Agonizes mu-opioid receptors and suppresses nociceptive neurotransmission while depressing respiratory drive.
      Source IDH51-01748F14C6EEB16B2AB6CDA7
      Mechanism level
      drug_specific
      Source IDH51-4C35E0C67215D146E03F2055
      Basic dosing orientation
      Adult infusion | Existing preparation record; use current package insert for indication-specific selection | Patient-specific dose; common bag 1,000 or 2,500 mcg | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | Common incremental dose 25 to 100 mcg | Common incremental dose 25 to 100 mcg | Patient- and indication-specific | See current package insert | IV push
      Source IDH51-D225413523FFEE8A32D8568A
      Administration orientation
      Titrate by mcg/hour or mcg/kg/hour; Slow IV over 1 to 2 minutes; 50 mcg/mL may be given undiluted or diluted per policy; Slow IV over 1 to 2 minutes
      Source IDH51-09505A77E6C475E842B212B8
      Renal and population orientation
      Separate renal reference: Open Renal Dosing Master (opens in a new tab)Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
      Source IDH51-1C4D9EB593547BBC6C66D34E
      Key safety orientation
      1. Respiratory depression, apnea, hypotension, and chest wall rigidity.
        Source IDH51-C005AA050CEBFD3B09140644
      2. Concomitant sedatives increase risk.
        Source IDH51-651E8490D8C82DF6FA5843EC
      Coverage path
      structured_local_snapshot
      Source IDH51-3D12E8C6DA0DDA231A53078A
      Coverage path label
      Structured GlobalRPh route snapshot
      Source IDH51-E1DE7F2458716A3FCF031B4E
      Legacy title
      Fentanyl
      Source IDH51-E755B655070DA6F9E7DA362B
      Review note
      First-look orientation only. Verify indication, patient population, weight basis, organ function, exact IV product, dose, concentration, compatibility, rate, and current labeling before use.
      Source IDH51-56E4BD09F57405A73542BBD0
      Search text
      Fentanyl Sedation, analgesia, and anesthesia Opioid analgesic Severe pain Procedural analgesia ICU analgesia and sedation Agonizes mu-opioid receptors and suppresses nociceptive neurotransmission while depressing respiratory drive. Adult infusion | Existing preparation record; use current package insert for indication-specific selection | Patient-specific dose; common bag 1,000 or 2,500 mcg | Not normalized in the preparation record | See current package insert and professional guidance | IV infusion; Adult | Common incremental dose 25 to 100 mcg | Common incremental dose 25 to 100 mcg | Patient- and indication-specific | See current package insert | IV push Titrate by mcg/hour or mcg/kg/hour; Slow IV over 1 to 2 minutes; 50 mcg/mL may be given undiluted or diluted per policy; Slow IV over 1 to 2 minutes Renal dosing status has not been locally normalized; use the current package insert before ordering or administration. Respiratory depression, apnea, hypotension, and chest wall rigidity. Concomitant sedatives increase risk. Structured GlobalRPh route snapshot
      Source IDH51-D4A9E8DC82C221F93F7ED886
      Official access mode
      search
      Source IDH51-5908DB30FD14906FC40B4E3C
      Official search query
      Fentanyl
      Source IDH51-E6C049FF9C2FEA92A686DBF0
      Official access reason
      A source-backed DailyMed search is available; select and confirm the exact IV product.
      Source IDH51-97F369DF652C52ACF4C266EC

      No separate structured rows were bundled for dialysis, CRRT. Historical article content and source links may cover these topics.

      Historical dilution and intermittent infusion preparation

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationAmountReconstitutionDiluentFinal volumeConcentrationRateStabilityNotes
      Source IDH51-233D27322DDA921EA9959B65
      Adult infusion
      Source IDH51-D70AB7A1EF1453789F5A1728
      Patient-specific dose; common bag 1,000 or 2,500 mcg
      Source IDH51-AD585CCF1B6E88BEF8E063E0
      Dilute concentrate or use premix.
      Source IDH51-5DDB8A51464E6B4422724492
      NS or D5W
      Source IDH51-5AE2329D48DE0049E031C323
      100 to 250 mL
      Source IDH51-9B4FE63CC88372B0104DD903
      Commonly 10 to 50 mcg/mL
      Source IDH51-D2D84BA1DBA4D760B80DDC52
      Titrate by mcg/hour or mcg/kg/hour
      Source IDH51-B4E101806A0FE539E8EC8764
      Use the shorter of current product labeling, validated stability data, and the applicable USP <797> sterility-based BUD ceiling.
      Source IDH51-7002235CB1C9C129F6A1B5B5
      Standardize concentration and dosing units.
      Source IDH51-84354955E54D574FDB0BB4F2

      Historical IV-push guidance

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationDose scopeConcentrationRateStatusNotes
      Source IDH51-A758FCB485AFB02A7F12FE96
      Adult
      Source IDH51-D25E34B88C48BA1FFCBA21B7
      Common incremental dose 25 to 100 mcg
      Source IDH51-B15366C74C7F28686DCC5B5F
      50 mcg/mL may be given undiluted or diluted per policy
      Source IDH51-ACAA1C9CC362266391C0C7B9
      Slow IV over 1 to 2 minutes
      Source IDH51-D72DCBDBE517121A7D534ABD
      Allowed with opioid monitoring
      Source IDH51-7EF7E757737288DBE1182FC5
      Rapid administration can cause chest wall rigidity, especially with large doses.
      Source IDH51-401DD59FFB41591AB1173F42
      Source IDH51-B511E03D0640968917F5FEE0
      Pediatric
      Source IDH51-927253A5E66498C4D8A86727
      Weight-based dose
      Source IDH51-E4EB1F737D26827561C32053
      Diluted or undiluted per age and policy
      Source IDH51-F21471F106E73384C29E3384
      Slow IV over 1 to 3 minutes
      Source IDH51-61E90E8DBF613A8B14E4A3E4
      Pediatric protocol required
      Source IDH51-FB8C54B93C2DC970CCF6EF5F

      Historical continuous-infusion guidance

      Recovered v5.1 source content; historical, awaiting current review.

      PopulationStandard concentrationInitial rateTitrationMaximumNotes
      Source IDH51-66A0237AF792EACC79E6F296
      Adult
      Source IDH51-540F014C9223E28CD3CCF356
      10 to 50 mcg/mL standardized concentration
      Source IDH51-7D2CD836B50ED9B2DEA5B503
      25 to 50 mcg/hour commonly
      Source IDH51-366C31ED6EFC7FB30414FA10
      Titrate to pain/sedation goal
      Source IDH51-42F844AB75B925DD1DAB3717
      Protocol-specific
      Source IDH51-BEFFB9356014B0148A4FDF0A
      Account for accumulation and interactions.
      Source IDH51-968B5023C6370EC13CC22EF4

      Historical indication and population dosing

      Recovered tables and source-separated snapshots; full clinical revalidation remains pending.

      Existing dose and route snapshots

      RoutePopulationIndicationDoseIntervalDurationAdministrationSource levelNotes
      Source IDH51-B4740A7EAA9B0025CC1FD78A
      IV infusion
      Source IDH51-E79A2100AC80E1F25C097CB9
      Adult infusion
      Source IDH51-19B15B1C745D2DA795CB4084
      Existing preparation record; use current package insert for indication-specific selection
      Source IDH51-D66258A1692876C876ABDD88
      Patient-specific dose; common bag 1,000 or 2,500 mcg
      Source IDH51-88F5846920CECF49B3085798
      Not normalized in the preparation record
      Source IDH51-8141CDA700702E56CE538A42
      See current package insert and professional guidance
      Source IDH51-9A328E57E386FED52A43DE98
      Titrate by mcg/hour or mcg/kg/hour
      Source IDH51-E01A8436E6FCE8D9F5225A53
      Existing GlobalRPh structured preparation snapshot
      Source IDH51-0E60F9442D36E4F126F5A3A4
      Standardize concentration and dosing units.
      Source IDH51-C8948BDC424A32E5022EEA04
      Source IDH51-CAE63CE7245CA03A50CB4BE9
      IV push
      Source IDH51-0707188DE73EF3ACA5FA3847
      Adult
      Source IDH51-5C72C750B39F69FDE19BDEC3
      Common incremental dose 25 to 100 mcg
      Source IDH51-B77F1432641DA65F1D9DDA6C
      Common incremental dose 25 to 100 mcg
      Source IDH51-5EBB1A2F0D338E6F2B00991E
      Patient- and indication-specific
      Source IDH51-E389BD895AAD7DB5B74706A8
      See current package insert
      Source IDH51-ED28F3F94963AF47B51EB723
      Slow IV over 1 to 2 minutes
      Source IDH51-5AD3247A5E974A1009BA1963
      Existing GlobalRPh IV push snapshot
      Source IDH51-9570EB03EC74A8B3F6C88130
      Allowed with opioid monitoring Rapid administration can cause chest wall rigidity, especially with large doses.
      Source IDH51-DEB721B93B570052B1102390
      Source IDH51-7B948372CBE0BA06CF5131A4
      IV push
      Source IDH51-4952FD40A25F63B11D8EAC8D
      Pediatric
      Source IDH51-C63A216AB3C2B6C54F35EC34
      Weight-based dose
      Source IDH51-16F7D0821BDAA17DC258D068
      Weight-based dose
      Source IDH51-CA2294C7229AB7A93DA4032E
      Patient- and indication-specific
      Source IDH51-99D6BB8D507F1D5E0F1FBA8B
      See current package insert
      Source IDH51-A19E96058EFEB902F6D0F647
      Slow IV over 1 to 3 minutes
      Source IDH51-A33D1CE939320AE08B32DCCA
      Existing GlobalRPh IV push snapshot
      Source IDH51-B14F2096635D5BA7E5B5F7D6
      Pediatric protocol required
      Source IDH51-368AC37AF1083046B4051579
      Source IDH51-07FA86B2D47A26B6B19177FA
      Continuous IV infusion
      Source IDH51-9E184A47918C2FE94E8141D4
      Adult
      Source IDH51-4D0544870A83BEA9943F0232
      Existing continuous-infusion record
      Source IDH51-3A7D5ACC7F8D1D887EF65D67
      25 to 50 mcg/hour commonly
      Source IDH51-42A1902868A9633AAE6A3A0F
      Continuous infusion; titration-specific
      Source IDH51-1692988151B7041175FB2033
      Clinical-response dependent
      Source IDH51-9424B098FF04618D8FADC488
      Titrate to pain/sedation goal
      Source IDH51-9B4D611AB7319502D79E860B
      Existing GlobalRPh continuous-infusion snapshot
      Source IDH51-5F96767C09C7DFB69CDC24D3
      Protocol-specific Account for accumulation and interactions.
      Source IDH51-F7C8354CF22E2976ACEDE72A

      Historical renal-function guidance

      Recovered v5.1 source content; historical, awaiting current review.

      Separate renal reference: Open Renal Dosing Master (opens in a new tab)
      Classification
      current_label_review_required
      Source IDH51-41E73D0EF4C6216C8DD0A53E
      Summary
      Renal dosing status has not been locally normalized; use the current package insert before ordering or administration.
      Source IDH51-E537777DC8261F395BAE6B39
      Method note
      Use the renal function estimate and body-size convention specified by the selected label or institutional protocol. Do not interchange Cockcroft-Gault CrCl, indexed eGFR, and de-indexed eGFR without confirming the dosing source.
      Source IDH51-AE14236F46024A5330698DC0

      Historical Common IV uses

      Recovered v5.1 source content; historical, awaiting current review.

      1. Severe pain
        Source IDH51-085CB1778D5DAB3B4F45C0E2
      2. Procedural analgesia
        Source IDH51-8A1E45B5A031A916B88D2B6A
      3. ICU analgesia and sedation
        Source IDH51-3EB280BA6EE60EC399151004

      Historical Warnings and safeguards

      Recovered v5.1 source content; historical, awaiting current review.

      1. Respiratory depression, apnea, hypotension, and chest wall rigidity.
        Source IDH51-DD3B93F3209ABF8E32DD967B
      2. Concomitant sedatives increase risk.
        Source IDH51-1AABA60771B823C3A6487055

      Historical Monitoring

      Recovered v5.1 source content; historical, awaiting current review.

      1. Continuous oxygenation and ventilation as clinically indicated
        Source IDH51-6461158547682E620F1561A2
      2. Sedation and pain scores
        Source IDH51-273715E42BE6627FB48277D8
      3. Blood pressure
        Source IDH51-8A59133C75CE204F21464C15
      Other recovered source fields and original editorial metadata

      Original status words such as current, verified, or normalized describe the historical source release. They do not change the clinical review status of this release.

      Catalog source fields

      Id
      fentanyl
      Source IDH51-94607B6BC2D935A50E4245AD
      Generic name
      Fentanyl
      Source IDH51-2C2FC1D2FDBC3BE5FA14645F
      Brand names
      1. Sublimaze
        Source IDH51-586364D5B0CF4CF9C38E2577
      Class
      Sedation, analgesia, and anesthesia
      Source IDH51-C7B473FC50A8BA1FAD57B233
      Subclass
      Opioid analgesic
      Source IDH51-920F841AB0423AF90DB45568
      Summary
      Potent opioid used by slow IV injection or continuous infusion with respiratory and sedation monitoring.
      Source IDH51-4548E17485313E46148A6E8C
      Populations
      1. Adult
        Source IDH51-EFB295CA84E31853AF53FFB2
      2. Pediatric
        Source IDH51-2AEF461371DD94F2E875012A
      3. Neonatal
        Source IDH51-60F4CEE0A1BE997651A3FAE2
      Evidence tier
      Core reference - verify current label
      Source IDH51-56D9673972927C08053848B9
      High alert
      true
      Source IDH51-B7ECD1B8F92FE9FB57DC4363
      Hazardous
      false
      Source IDH51-FA99D64D442728D2F11DB431
      Status
      Active
      Source IDH51-05220F136CBA81F49ACAECA4
      Reviewed
      2026-08-29
      Source IDH51-020B19918ED8CBADE72A84FD
      Version added
      1.0
      Source IDH51-8C47D19E71C0E7CCAC5ED3DD
      Sources
      LabelUrlKind
      Source IDH51-36FBC1846FA13F98A897433B
      DailyMed label search
      Source IDH51-F7BD2D5F8903C84647EC1B14
      https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fentanyl (opens in a new tab)
      Source IDH51-B0932E7598BCAAE5FB46D436
      Primary
      Source IDH51-722959DC22BC38938F56EE14
      Source IDH51-C83047E1392E58A3B4F7F115
      GlobalRPh legacy IV dilution monograph
      Source IDH51-D3886AF1113EBD99B4F2DE18
      legacy:auto
      Source IDH51-11E39F1A01880F0FFB3E34D4
      Legacy
      Source IDH51-459DB341443BCD46F225DA25
      Legacy title
      Fentanyl
      Source IDH51-612F3D45A066894E911C36B5
      Clinical release verification
      Audit version
      3.4
      Source IDH51-EB1356531669901C43811FE3
      Audited on
      2026-08-30
      Source IDH51-5024EAD5CE9DC9440697F31D
      Level
      amber
      Source IDH51-63D472ED8BA69B13218684AA
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-40ECE910F07600000BDA3359
      Exact current label candidate
      false
      Source IDH51-48287B25B5640DA7AE1A280A
      Numeric support ratio
      0
      Source IDH51-DC9129E1D1630334CC9F84F1
      Reference url count
      1
      Source IDH51-4CF3B8E3D3EE4E17A6A29170
      Broken reference count
      0
      Source IDH51-BE2980F6B96961D34BCAD53B
      Point of use confirmation required
      true
      Source IDH51-024134A0800A3426C46D4712
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-2BB380978D5EF74DA36171EB
      Dailymed search url
      https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fentanyl (opens in a new tab)
      Source IDH51-0FF7230429950CEF3FB1BD3F

      Dosing source fields

      Id
      fentanyl
      Source IDH51-7CD1A590EC83080BF46BC6F3
      Generic name
      Fentanyl
      Source IDH51-00F6EFB9C37CF02717979DE3
      Coverage status
      direct_official_label_access_plus_local_snapshot
      Source IDH51-5D44755A0A918E8721EF144B
      Package insert
      Query name
      Fentanyl
      Source IDH51-47E5796079B8FA50A8505A5D
      Product and route must match
      true
      Source IDH51-573EE5739353A6766C728923
      Live current label enabled
      false
      Source IDH51-3640D508C4A85DFC33BDD41D
      Source priority
      Reviewed local summary when available, then a verified DailyMed label or product search when available, followed by professional references and institutional policy.
      Source IDH51-4B598DA8A79FF889ECB6CFA0
      Direct official label access enabled
      true
      Source IDH51-55F7B10DEBCA5E3BD380459E
      Outbound server request required
      false
      Source IDH51-2B86A080B6FEAFBA8E6FD483
      Local summary status
      not_bundled
      Source IDH51-4CB4A3A5BBCB5DB4308C299A
      Clinical review
      Locally normalized
      false
      Source IDH51-FD1D949B22157873522BD117
      Reviewed
      2026-08-29
      Source IDH51-DD93AC053CD60E3E2A4A5D7D
      Status
      Direct official package-insert access enabled; indication-specific local normalization pending.
      Source IDH51-EC0995914403DD9FEA27E61D
      Clinical release verification
      Audit version
      3.4
      Source IDH51-EC5294E77A0AD396D26A5FFA
      Audited on
      2026-08-30
      Source IDH51-28D956FC956BE514372C511F
      Level
      amber
      Source IDH51-2D81E98E190278C64AF9E7D8
      Release gate
      trusted_professional_source_present_exact_label_unconfirmed
      Source IDH51-B5A44EF5B71D371D73A722B8
      Exact current label candidate
      false
      Source IDH51-765E9B67EFB016E1579C15CC
      Numeric support ratio
      0
      Source IDH51-3583F889056CBC34F4BF2B79
      Reference url count
      1
      Source IDH51-A618083BA64C5EA24154587C
      Broken reference count
      0
      Source IDH51-43F1B6707BAABDFA0264C86D
      Point of use confirmation required
      true
      Source IDH51-AB6B4ED3EA241AF2A69C1BE0
      Note
      Do not treat this record as a fully current product-specific monograph until the exact IV formulation and current sources are confirmed.
      Source IDH51-46FC5A68780288A5818C7ACB
      Dailymed search url
      https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fentanyl (opens in a new tab)
      Source IDH51-5D3D4F35F1AEEA345A241DC0
      Historical preparation assessment

      Recovered v5.1 source content; historical, awaiting current review.

      Id
      fentanyl
      Source IDH51-5AACCC949396E16667FA7A02
      Name
      Fentanyl
      Source IDH51-21BC3DCDEA1A45792F7DF62A
      Brands
      Sublimaze
      Source IDH51-F6694D69AD850997FBC20C79
      Therapeutic class
      Sedation, analgesia, and anesthesia
      Source IDH51-554D27909F021F501A34EC6B
      Review version
      3.1
      Source IDH51-9EC9A798EE441033B269A060
      Review date
      2026-08-30
      Source IDH51-67DD9325E1C4F958ED2D35D7
      Release status
      structured_record_current_label_not_confirmed
      Source IDH51-D7F24E86B981D865C5E96ED4
      Market status
      Status
      no_current_us_iv_spl_confirmed
      Source IDH51-FEE35FC48907FA1BD35741C7
      Basis
      No high-confidence current IV SPL was automatically selected; legacy information is segregated
      Source IDH51-DCAEADDE4950447A48BFB14B
      Ten point assessment
      Exact formulation
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-EC4C7682051E76EE76ACD9CD
      Reconstitution concentration
      Dilute concentrate or use premix.
      Source IDH51-762E204B49300F0883B08646
      Maximum or recommended final concentration
      10 to 50 mcg/mL standardized concentration
      Source IDH51-4BEB50FC588C3D3925AA9B95
      Appropriate standardized containers
      100 to 250 mL
      Source IDH51-55925282096F1F822E6EC2C5
      Adult dosing range
      Patient-specific dose; common bag 1,000 or 2,500 mcg Common incremental dose 25 to 100 mcg Weight-based dose 25 to 50 mcg/hour commonly Common incremental dose 25 to 100 mcg Weight-based dose
      Source IDH51-98013553A8748E126E182118
      Pediatric dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-3C500394C50811D8C0FA715A
      Neonatal dosing range
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-A56FA3DA60DC3AE8BB0B4957
      Infusion time
      Titrate by mcg/hour or mcg/kg/hour Slow IV over 1 to 2 minutes Slow IV over 1 to 3 minutes 25 to 50 mcg/hour commonly
      Source IDH51-4BF7F112CC2B36B71AD4460B
      Fluid restriction alternatives
      Not established in the currently normalized record. Use the current-label panel before clinical use.
      Source IDH51-1E2EF5A198E95C72415B7BD4
      Current manufacturer labeling
      Match confidence
      unresolved
      Source IDH51-CEA9284C1F70A9B9D65E826C
      Field provenance
      Exact formulation
      Primary
      not_found
      Source IDH51-209B823A6806B3A6D322F7CE
      Reconstitution concentration
      Primary
      existing_structured_record
      Source IDH51-D304F39CD298C32FA97ABE4B
      Maximum or recommended final concentration
      Primary
      existing_structured_record
      Source IDH51-505C2C64583F282B725B5421
      Appropriate standardized containers
      Primary
      existing_structured_record
      Source IDH51-AA1C1BD227483D8098D64C5B
      Adult dosing range
      Primary
      existing_structured_record
      Source IDH51-49E2B78774EDF041B8DC91B0
      Pediatric dosing range
      Primary
      not_found
      Source IDH51-6C3530521C69B47E151E7531
      Neonatal dosing range
      Primary
      not_found
      Source IDH51-B6741FABB33A478D1FFC7CD3
      Infusion time
      Primary
      existing_structured_record
      Source IDH51-D5E935C50C47E13AF3F2EA7A
      Fluid restriction alternatives
      Primary
      not_found
      Source IDH51-A09C9B2BF8E883D1583039D1
      Current manufacturer labeling
      Primary
      DailyMed search gateway
      Source IDH51-E9192FADD28C758F0CA654DB
      Population applicability
      Adult
      Applicability
      supported_or_source_present
      Source IDH51-9EA11DD59C29051B2AFD9B27
      Guide generation allowed
      true
      Source IDH51-CD92BFD854DA6FB89ADFB333
      Pediatric
      Applicability
      supported_or_source_present
      Source IDH51-6E475F68F4CB25A8E06A1ED2
      Guide generation allowed
      false
      Source IDH51-30AC23E8F69C3A156CC8EAFD
      Neonatal
      Applicability
      supported_or_source_present
      Source IDH51-F716BEEAAD768DAFB84A0121
      Guide generation allowed
      false
      Source IDH51-9920C5AC571108CBD518951C
      Route presence
      Structured dilution
      true
      Source IDH51-411CB0F060E4CCC2CAB762A2
      Iv push
      true
      Source IDH51-0F9C23754F088A5E692E152D
      Continuous infusion
      true
      Source IDH51-8D294A74F79AB8045B05AB6A
      Pediatric source
      true
      Source IDH51-36494AC209A0353095F667FB
      Neonatal source
      true
      Source IDH51-7AC9DFD8D4F77484C93ABB14
      Legacy reference
      Status
      not_available
      Source IDH51-631F5B2B25438E4BF4F40C97
      Label resolution
      Status
      build_environment_network_unavailable
      Source IDH51-150D2D015270B65381A24968
      Concentration values detected
      LowHighUnitText
      Source IDH51-476DF6039AD65D36FC6793F2
      10
      Source IDH51-FD17164F0E33D6B943647AB8
      50
      Source IDH51-427DDD207406CC9EC556ADD7
      mcg
      Source IDH51-053DAF8DEB55D8B61A0A9537
      10 to 50 mcg/mL
      Source IDH51-7F0D203345A8880CC836AEF9
      Source files
      1. catalog.json
        Source IDH51-9F9CD996F4DBF7ADB139EFDB
      2. dosing.json
        Source IDH51-7F433287F946BC8BBB0BE76C
      3. legacy-map.json
        Source IDH51-F493AC5F5A9288E9C4534B42
      Clinical release note
      Preparation instructions are released only at the evidence level shown. Legacy content remains visibly separate. Exact product, NDC, route, current labeling, and institutional policy must be confirmed.
      Source IDH51-BD39F2F3F75B27B90871A5B0
      Historical statement IDs and source locations

      These IDs identify recovered source units. They are not evidence-qualified clinical claims.

      Historical IDOriginal source locationStatus
      H51-94607B6BC2D935A50E4245ADcatalog.json
      /records/102/id
      Historical; current review incomplete
      H51-2C2FC1D2FDBC3BE5FA14645Fcatalog.json
      /records/102/generic_name
      Historical; current review incomplete
      H51-586364D5B0CF4CF9C38E2577catalog.json
      /records/102/brand_names/0
      Historical; current review incomplete
      H51-C7B473FC50A8BA1FAD57B233catalog.json
      /records/102/class
      Historical; current review incomplete
      H51-920F841AB0423AF90DB45568catalog.json
      /records/102/subclass
      Historical; current review incomplete
      H51-4548E17485313E46148A6E8Ccatalog.json
      /records/102/summary
      Historical; current review incomplete
      H51-085CB1778D5DAB3B4F45C0E2catalog.json
      /records/102/common_uses/0
      Historical; current review incomplete
      H51-8A1E45B5A031A916B88D2B6Acatalog.json
      /records/102/common_uses/1
      Historical; current review incomplete
      H51-3EB280BA6EE60EC399151004catalog.json
      /records/102/common_uses/2
      Historical; current review incomplete
      H51-233D27322DDA921EA9959B65catalog.json
      /records/102/preparations/0
      Historical; current review incomplete
      H51-D70AB7A1EF1453789F5A1728catalog.json
      /records/102/preparations/0/population
      Historical; current review incomplete
      H51-AD585CCF1B6E88BEF8E063E0catalog.json
      /records/102/preparations/0/amount
      Historical; current review incomplete
      H51-5DDB8A51464E6B4422724492catalog.json
      /records/102/preparations/0/reconstitution
      Historical; current review incomplete
      H51-5AE2329D48DE0049E031C323catalog.json
      /records/102/preparations/0/diluent
      Historical; current review incomplete
      H51-9B4FE63CC88372B0104DD903catalog.json
      /records/102/preparations/0/final_volume
      Historical; current review incomplete
      H51-D2D84BA1DBA4D760B80DDC52catalog.json
      /records/102/preparations/0/concentration
      Historical; current review incomplete
      H51-B4E101806A0FE539E8EC8764catalog.json
      /records/102/preparations/0/rate
      Historical; current review incomplete
      H51-7002235CB1C9C129F6A1B5B5catalog.json
      /records/102/preparations/0/stability
      Historical; current review incomplete
      H51-84354955E54D574FDB0BB4F2catalog.json
      /records/102/preparations/0/notes
      Historical; current review incomplete
      H51-A758FCB485AFB02A7F12FE96catalog.json
      /records/102/iv_push/0
      Historical; current review incomplete
      H51-D25E34B88C48BA1FFCBA21B7catalog.json
      /records/102/iv_push/0/population
      Historical; current review incomplete
      H51-B15366C74C7F28686DCC5B5Fcatalog.json
      /records/102/iv_push/0/dose_scope
      Historical; current review incomplete
      H51-ACAA1C9CC362266391C0C7B9catalog.json
      /records/102/iv_push/0/concentration
      Historical; current review incomplete
      H51-D72DCBDBE517121A7D534ABDcatalog.json
      /records/102/iv_push/0/rate
      Historical; current review incomplete
      H51-7EF7E757737288DBE1182FC5catalog.json
      /records/102/iv_push/0/status
      Historical; current review incomplete
      H51-401DD59FFB41591AB1173F42catalog.json
      /records/102/iv_push/0/notes
      Historical; current review incomplete
      H51-B511E03D0640968917F5FEE0catalog.json
      /records/102/iv_push/1
      Historical; current review incomplete
      H51-927253A5E66498C4D8A86727catalog.json
      /records/102/iv_push/1/population
      Historical; current review incomplete
      H51-E4EB1F737D26827561C32053catalog.json
      /records/102/iv_push/1/dose_scope
      Historical; current review incomplete
      H51-F21471F106E73384C29E3384catalog.json
      /records/102/iv_push/1/concentration
      Historical; current review incomplete
      H51-61E90E8DBF613A8B14E4A3E4catalog.json
      /records/102/iv_push/1/rate
      Historical; current review incomplete
      H51-FB8C54B93C2DC970CCF6EF5Fcatalog.json
      /records/102/iv_push/1/status
      Historical; current review incomplete
      H51-88F4F48B3F20C6CD3D17DF6Ecatalog.json
      /records/102/iv_push/1/notes
      Historical; current review incomplete
      H51-66A0237AF792EACC79E6F296catalog.json
      /records/102/continuous_infusions/0
      Historical; current review incomplete
      H51-540F014C9223E28CD3CCF356catalog.json
      /records/102/continuous_infusions/0/population
      Historical; current review incomplete
      H51-7D2CD836B50ED9B2DEA5B503catalog.json
      /records/102/continuous_infusions/0/standard_concentration
      Historical; current review incomplete
      H51-366C31ED6EFC7FB30414FA10catalog.json
      /records/102/continuous_infusions/0/initial_rate
      Historical; current review incomplete
      H51-42F844AB75B925DD1DAB3717catalog.json
      /records/102/continuous_infusions/0/titration
      Historical; current review incomplete
      H51-BEFFB9356014B0148A4FDF0Acatalog.json
      /records/102/continuous_infusions/0/maximum
      Historical; current review incomplete
      H51-968B5023C6370EC13CC22EF4catalog.json
      /records/102/continuous_infusions/0/notes
      Historical; current review incomplete
      H51-DD3B93F3209ABF8E32DD967Bcatalog.json
      /records/102/warnings/0
      Historical; current review incomplete
      H51-1AABA60771B823C3A6487055catalog.json
      /records/102/warnings/1
      Historical; current review incomplete
      H51-6461158547682E620F1561A2catalog.json
      /records/102/monitoring/0
      Historical; current review incomplete
      H51-273715E42BE6627FB48277D8catalog.json
      /records/102/monitoring/1
      Historical; current review incomplete
      H51-8A59133C75CE204F21464C15catalog.json
      /records/102/monitoring/2
      Historical; current review incomplete
      H51-EFB295CA84E31853AF53FFB2catalog.json
      /records/102/populations/0
      Historical; current review incomplete
      H51-2AEF461371DD94F2E875012Acatalog.json
      /records/102/populations/1
      Historical; current review incomplete
      H51-60F4CEE0A1BE997651A3FAE2catalog.json
      /records/102/populations/2
      Historical; current review incomplete
      H51-56D9673972927C08053848B9catalog.json
      /records/102/evidence_tier
      Historical; current review incomplete
      H51-B7ECD1B8F92FE9FB57DC4363catalog.json
      /records/102/high_alert
      Historical; current review incomplete
      H51-FA99D64D442728D2F11DB431catalog.json
      /records/102/hazardous
      Historical; current review incomplete
      H51-05220F136CBA81F49ACAECA4catalog.json
      /records/102/status
      Historical; current review incomplete
      H51-020B19918ED8CBADE72A84FDcatalog.json
      /records/102/reviewed
      Historical; current review incomplete
      H51-8C47D19E71C0E7CCAC5ED3DDcatalog.json
      /records/102/version_added
      Historical; current review incomplete
      H51-36FBC1846FA13F98A897433Bcatalog.json
      /records/102/sources/0
      Historical; current review incomplete
      H51-F7BD2D5F8903C84647EC1B14catalog.json
      /records/102/sources/0/label
      Historical; current review incomplete
      H51-B0932E7598BCAAE5FB46D436catalog.json
      /records/102/sources/0/url
      Historical; current review incomplete
      H51-722959DC22BC38938F56EE14catalog.json
      /records/102/sources/0/kind
      Historical; current review incomplete
      H51-C83047E1392E58A3B4F7F115catalog.json
      /records/102/sources/1
      Historical; current review incomplete
      H51-D3886AF1113EBD99B4F2DE18catalog.json
      /records/102/sources/1/label
      Historical; current review incomplete
      H51-11E39F1A01880F0FFB3E34D4catalog.json
      /records/102/sources/1/url
      Historical; current review incomplete
      H51-459DB341443BCD46F225DA25catalog.json
      /records/102/sources/1/kind
      Historical; current review incomplete
      H51-612F3D45A066894E911C36B5catalog.json
      /records/102/legacy_title
      Historical; current review incomplete
      H51-EB1356531669901C43811FE3catalog.json
      /records/102/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-5024EAD5CE9DC9440697F31Dcatalog.json
      /records/102/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-63D472ED8BA69B13218684AAcatalog.json
      /records/102/clinical_release_verification/level
      Historical; current review incomplete
      H51-40ECE910F07600000BDA3359catalog.json
      /records/102/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-48287B25B5640DA7AE1A280Acatalog.json
      /records/102/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-2DC22FC5D3F61F46D55B4EC4catalog.json
      /records/102/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-C24ACD63E0B69EF4DA9D906Fcatalog.json
      /records/102/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-DC9129E1D1630334CC9F84F1catalog.json
      /records/102/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-4CF3B8E3D3EE4E17A6A29170catalog.json
      /records/102/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-BE2980F6B96961D34BCAD53Bcatalog.json
      /records/102/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-024134A0800A3426C46D4712catalog.json
      /records/102/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-2BB380978D5EF74DA36171EBcatalog.json
      /records/102/clinical_release_verification/note
      Historical; current review incomplete
      H51-0FF7230429950CEF3FB1BD3Fcatalog.json
      /records/102/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-7CD1A590EC83080BF46BC6F3dosing.json
      /records/102/id
      Historical; current review incomplete
      H51-00F6EFB9C37CF02717979DE3dosing.json
      /records/102/generic_name
      Historical; current review incomplete
      H51-5D44755A0A918E8721EF144Bdosing.json
      /records/102/coverage_status
      Historical; current review incomplete
      H51-47E5796079B8FA50A8505A5Ddosing.json
      /records/102/package_insert/query_name
      Historical; current review incomplete
      H51-15F4CBC88ECD3AFD68FA4972dosing.json
      /records/102/package_insert/preferred_setid
      Historical; current review incomplete
      H51-573EE5739353A6766C728923dosing.json
      /records/102/package_insert/product_and_route_must_match
      Historical; current review incomplete
      H51-3640D508C4A85DFC33BDD41Ddosing.json
      /records/102/package_insert/live_current_label_enabled
      Historical; current review incomplete
      H51-4B598DA8A79FF889ECB6CFA0dosing.json
      /records/102/package_insert/source_priority
      Historical; current review incomplete
      H51-55F7B10DEBCA5E3BD380459Edosing.json
      /records/102/package_insert/direct_official_label_access_enabled
      Historical; current review incomplete
      H51-2B86A080B6FEAFBA8E6FD483dosing.json
      /records/102/package_insert/outbound_server_request_required
      Historical; current review incomplete
      H51-4CB4A3A5BBCB5DB4308C299Adosing.json
      /records/102/package_insert/local_summary_status
      Historical; current review incomplete
      H51-41E73D0EF4C6216C8DD0A53Edosing.json
      /records/102/renal/classification
      Historical; current review incomplete
      H51-E537777DC8261F395BAE6B39dosing.json
      /records/102/renal/summary
      Historical; current review incomplete
      H51-AE14236F46024A5330698DC0dosing.json
      /records/102/renal/method_note
      Historical; current review incomplete
      H51-B4740A7EAA9B0025CC1FD78Adosing.json
      /records/102/existing_route_snapshots/0
      Historical; current review incomplete
      H51-E79A2100AC80E1F25C097CB9dosing.json
      /records/102/existing_route_snapshots/0/route
      Historical; current review incomplete
      H51-19B15B1C745D2DA795CB4084dosing.json
      /records/102/existing_route_snapshots/0/population
      Historical; current review incomplete
      H51-D66258A1692876C876ABDD88dosing.json
      /records/102/existing_route_snapshots/0/indication
      Historical; current review incomplete
      H51-88F5846920CECF49B3085798dosing.json
      /records/102/existing_route_snapshots/0/dose
      Historical; current review incomplete
      H51-8141CDA700702E56CE538A42dosing.json
      /records/102/existing_route_snapshots/0/interval
      Historical; current review incomplete
      H51-9A328E57E386FED52A43DE98dosing.json
      /records/102/existing_route_snapshots/0/duration
      Historical; current review incomplete
      H51-E01A8436E6FCE8D9F5225A53dosing.json
      /records/102/existing_route_snapshots/0/administration
      Historical; current review incomplete
      H51-0E60F9442D36E4F126F5A3A4dosing.json
      /records/102/existing_route_snapshots/0/source_level
      Historical; current review incomplete
      H51-C8948BDC424A32E5022EEA04dosing.json
      /records/102/existing_route_snapshots/0/notes
      Historical; current review incomplete
      H51-CAE63CE7245CA03A50CB4BE9dosing.json
      /records/102/existing_route_snapshots/1
      Historical; current review incomplete
      H51-0707188DE73EF3ACA5FA3847dosing.json
      /records/102/existing_route_snapshots/1/route
      Historical; current review incomplete
      H51-5C72C750B39F69FDE19BDEC3dosing.json
      /records/102/existing_route_snapshots/1/population
      Historical; current review incomplete
      H51-B77F1432641DA65F1D9DDA6Cdosing.json
      /records/102/existing_route_snapshots/1/indication
      Historical; current review incomplete
      H51-5EBB1A2F0D338E6F2B00991Edosing.json
      /records/102/existing_route_snapshots/1/dose
      Historical; current review incomplete
      H51-E389BD895AAD7DB5B74706A8dosing.json
      /records/102/existing_route_snapshots/1/interval
      Historical; current review incomplete
      H51-ED28F3F94963AF47B51EB723dosing.json
      /records/102/existing_route_snapshots/1/duration
      Historical; current review incomplete
      H51-5AD3247A5E974A1009BA1963dosing.json
      /records/102/existing_route_snapshots/1/administration
      Historical; current review incomplete
      H51-9570EB03EC74A8B3F6C88130dosing.json
      /records/102/existing_route_snapshots/1/source_level
      Historical; current review incomplete
      H51-DEB721B93B570052B1102390dosing.json
      /records/102/existing_route_snapshots/1/notes
      Historical; current review incomplete
      H51-7B948372CBE0BA06CF5131A4dosing.json
      /records/102/existing_route_snapshots/2
      Historical; current review incomplete
      H51-4952FD40A25F63B11D8EAC8Ddosing.json
      /records/102/existing_route_snapshots/2/route
      Historical; current review incomplete
      H51-C63A216AB3C2B6C54F35EC34dosing.json
      /records/102/existing_route_snapshots/2/population
      Historical; current review incomplete
      H51-16F7D0821BDAA17DC258D068dosing.json
      /records/102/existing_route_snapshots/2/indication
      Historical; current review incomplete
      H51-CA2294C7229AB7A93DA4032Edosing.json
      /records/102/existing_route_snapshots/2/dose
      Historical; current review incomplete
      H51-99D6BB8D507F1D5E0F1FBA8Bdosing.json
      /records/102/existing_route_snapshots/2/interval
      Historical; current review incomplete
      H51-A19E96058EFEB902F6D0F647dosing.json
      /records/102/existing_route_snapshots/2/duration
      Historical; current review incomplete
      H51-A33D1CE939320AE08B32DCCAdosing.json
      /records/102/existing_route_snapshots/2/administration
      Historical; current review incomplete
      H51-B14F2096635D5BA7E5B5F7D6dosing.json
      /records/102/existing_route_snapshots/2/source_level
      Historical; current review incomplete
      H51-368AC37AF1083046B4051579dosing.json
      /records/102/existing_route_snapshots/2/notes
      Historical; current review incomplete
      H51-07FA86B2D47A26B6B19177FAdosing.json
      /records/102/existing_route_snapshots/3
      Historical; current review incomplete
      H51-9E184A47918C2FE94E8141D4dosing.json
      /records/102/existing_route_snapshots/3/route
      Historical; current review incomplete
      H51-4D0544870A83BEA9943F0232dosing.json
      /records/102/existing_route_snapshots/3/population
      Historical; current review incomplete
      H51-3A7D5ACC7F8D1D887EF65D67dosing.json
      /records/102/existing_route_snapshots/3/indication
      Historical; current review incomplete
      H51-42A1902868A9633AAE6A3A0Fdosing.json
      /records/102/existing_route_snapshots/3/dose
      Historical; current review incomplete
      H51-1692988151B7041175FB2033dosing.json
      /records/102/existing_route_snapshots/3/interval
      Historical; current review incomplete
      H51-9424B098FF04618D8FADC488dosing.json
      /records/102/existing_route_snapshots/3/duration
      Historical; current review incomplete
      H51-9B4D611AB7319502D79E860Bdosing.json
      /records/102/existing_route_snapshots/3/administration
      Historical; current review incomplete
      H51-5F96767C09C7DFB69CDC24D3dosing.json
      /records/102/existing_route_snapshots/3/source_level
      Historical; current review incomplete
      H51-F7C8354CF22E2976ACEDE72Adosing.json
      /records/102/existing_route_snapshots/3/notes
      Historical; current review incomplete
      H51-FD1D949B22157873522BD117dosing.json
      /records/102/clinical_review/locally_normalized
      Historical; current review incomplete
      H51-DD93AC053CD60E3E2A4A5D7Ddosing.json
      /records/102/clinical_review/reviewed
      Historical; current review incomplete
      H51-EC0995914403DD9FEA27E61Ddosing.json
      /records/102/clinical_review/status
      Historical; current review incomplete
      H51-EC5294E77A0AD396D26A5FFAdosing.json
      /records/102/clinical_release_verification/audit_version
      Historical; current review incomplete
      H51-28D956FC956BE514372C511Fdosing.json
      /records/102/clinical_release_verification/audited_on
      Historical; current review incomplete
      H51-2D81E98E190278C64AF9E7D8dosing.json
      /records/102/clinical_release_verification/level
      Historical; current review incomplete
      H51-B5A44EF5B71D371D73A722B8dosing.json
      /records/102/clinical_release_verification/release_gate
      Historical; current review incomplete
      H51-765E9B67EFB016E1579C15CCdosing.json
      /records/102/clinical_release_verification/exact_current_label_candidate
      Historical; current review incomplete
      H51-290A74C58E1EC8BC47AE83BEdosing.json
      /records/102/clinical_release_verification/selected_setid
      Historical; current review incomplete
      H51-83A289703E2635C94CAA108Ddosing.json
      /records/102/clinical_release_verification/selected_label_title
      Historical; current review incomplete
      H51-3583F889056CBC34F4BF2B79dosing.json
      /records/102/clinical_release_verification/numeric_support_ratio
      Historical; current review incomplete
      H51-A618083BA64C5EA24154587Cdosing.json
      /records/102/clinical_release_verification/reference_url_count
      Historical; current review incomplete
      H51-43F1B6707BAABDFA0264C86Ddosing.json
      /records/102/clinical_release_verification/broken_reference_count
      Historical; current review incomplete
      H51-AB6B4ED3EA241AF2A69C1BE0dosing.json
      /records/102/clinical_release_verification/point_of_use_confirmation_required
      Historical; current review incomplete
      H51-46FC5A68780288A5818C7ACBdosing.json
      /records/102/clinical_release_verification/note
      Historical; current review incomplete
      H51-5D3D4F35F1AEEA345A241DC0dosing.json
      /records/102/clinical_release_verification/dailymed_search_url
      Historical; current review incomplete
      H51-08BE96338526854050BF8B28first-look-v5.1.json
      /records/102/id
      Historical; current review incomplete
      H51-F0D97DD6C1BA088AAF200374first-look-v5.1.json
      /records/102/generic_name
      Historical; current review incomplete
      H51-EF8EAF853F9DBA93E8955EA3first-look-v5.1.json
      /records/102/class
      Historical; current review incomplete
      H51-3704C0A9C88CAFEFF4EBD05Afirst-look-v5.1.json
      /records/102/subclass
      Historical; current review incomplete
      H51-32F3E74C18374975E003C7C7first-look-v5.1.json
      /records/102/primary_uses/0
      Historical; current review incomplete
      H51-3713D5147108F1637C6741BCfirst-look-v5.1.json
      /records/102/primary_uses/1
      Historical; current review incomplete
      H51-D35A001A04C277A76CDC21E0first-look-v5.1.json
      /records/102/primary_uses/2
      Historical; current review incomplete
      H51-01748F14C6EEB16B2AB6CDA7first-look-v5.1.json
      /records/102/mechanism
      Historical; current review incomplete
      H51-4C35E0C67215D146E03F2055first-look-v5.1.json
      /records/102/mechanism_level
      Historical; current review incomplete
      H51-D225413523FFEE8A32D8568Afirst-look-v5.1.json
      /records/102/basic_dosing_orientation
      Historical; current review incomplete
      H51-09505A77E6C475E842B212B8first-look-v5.1.json
      /records/102/administration_orientation
      Historical; current review incomplete
      H51-1C4D9EB593547BBC6C66D34Efirst-look-v5.1.json
      /records/102/renal_and_population_orientation
      Historical; current review incomplete
      H51-C005AA050CEBFD3B09140644first-look-v5.1.json
      /records/102/key_safety_orientation/0
      Historical; current review incomplete
      H51-651E8490D8C82DF6FA5843ECfirst-look-v5.1.json
      /records/102/key_safety_orientation/1
      Historical; current review incomplete
      H51-3D12E8C6DA0DDA231A53078Afirst-look-v5.1.json
      /records/102/coverage_path
      Historical; current review incomplete
      H51-E1DE7F2458716A3FCF031B4Efirst-look-v5.1.json
      /records/102/coverage_path_label
      Historical; current review incomplete
      H51-8973109D25A8A6EA79CC0150first-look-v5.1.json
      /records/102/official_label_url
      Historical; current review incomplete
      H51-E755B655070DA6F9E7DA362Bfirst-look-v5.1.json
      /records/102/legacy_title
      Historical; current review incomplete
      H51-56E4BD09F57405A73542BBD0first-look-v5.1.json
      /records/102/review_note
      Historical; current review incomplete
      H51-D4A9E8DC82C221F93F7ED886first-look-v5.1.json
      /records/102/search_text
      Historical; current review incomplete
      H51-5C058A7C9076A7F68557927Ffirst-look-v5.1.json
      /records/102/official_search_url
      Historical; current review incomplete
      H51-5908DB30FD14906FC40B4E3Cfirst-look-v5.1.json
      /records/102/official_access_mode
      Historical; current review incomplete
      H51-B312BCB7B04922937D35F373first-look-v5.1.json
      /records/102/official_access_url
      Historical; current review incomplete
      H51-E6C049FF9C2FEA92A686DBF0first-look-v5.1.json
      /records/102/official_search_query
      Historical; current review incomplete
      H51-97F369DF652C52ACF4C266ECfirst-look-v5.1.json
      /records/102/official_access_reason
      Historical; current review incomplete
      H51-5AACCC949396E16667FA7A02preparation-assessments-v3.8.json
      /102/id
      Historical; current review incomplete
      H51-21BC3DCDEA1A45792F7DF62Apreparation-assessments-v3.8.json
      /102/name
      Historical; current review incomplete
      H51-F6694D69AD850997FBC20C79preparation-assessments-v3.8.json
      /102/brands
      Historical; current review incomplete
      H51-554D27909F021F501A34EC6Bpreparation-assessments-v3.8.json
      /102/therapeutic_class
      Historical; current review incomplete
      H51-9EC9A798EE441033B269A060preparation-assessments-v3.8.json
      /102/review_version
      Historical; current review incomplete
      H51-67DD9325E1C4F958ED2D35D7preparation-assessments-v3.8.json
      /102/review_date
      Historical; current review incomplete
      H51-D7F24E86B981D865C5E96ED4preparation-assessments-v3.8.json
      /102/release_status
      Historical; current review incomplete
      H51-FEE35FC48907FA1BD35741C7preparation-assessments-v3.8.json
      /102/market_status/status
      Historical; current review incomplete
      H51-DCAEADDE4950447A48BFB14Bpreparation-assessments-v3.8.json
      /102/market_status/basis
      Historical; current review incomplete
      H51-EC4C7682051E76EE76ACD9CDpreparation-assessments-v3.8.json
      /102/ten_point_assessment/exact_formulation
      Historical; current review incomplete
      H51-762E204B49300F0883B08646preparation-assessments-v3.8.json
      /102/ten_point_assessment/reconstitution_concentration
      Historical; current review incomplete
      H51-4BEB50FC588C3D3925AA9B95preparation-assessments-v3.8.json
      /102/ten_point_assessment/maximum_or_recommended_final_concentration
      Historical; current review incomplete
      H51-55925282096F1F822E6EC2C5preparation-assessments-v3.8.json
      /102/ten_point_assessment/appropriate_standardized_containers
      Historical; current review incomplete
      H51-98013553A8748E126E182118preparation-assessments-v3.8.json
      /102/ten_point_assessment/adult_dosing_range
      Historical; current review incomplete
      H51-3C500394C50811D8C0FA715Apreparation-assessments-v3.8.json
      /102/ten_point_assessment/pediatric_dosing_range
      Historical; current review incomplete
      H51-A56FA3DA60DC3AE8BB0B4957preparation-assessments-v3.8.json
      /102/ten_point_assessment/neonatal_dosing_range
      Historical; current review incomplete
      H51-4BF7F112CC2B36B71AD4460Bpreparation-assessments-v3.8.json
      /102/ten_point_assessment/infusion_time
      Historical; current review incomplete
      H51-1E2EF5A198E95C72415B7BD4preparation-assessments-v3.8.json
      /102/ten_point_assessment/fluid_restriction_alternatives
      Historical; current review incomplete
      H51-4D1C6623EA6F603DE9DA2469preparation-assessments-v3.8.json
      /102/ten_point_assessment/current_manufacturer_labeling/setid
      Historical; current review incomplete
      H51-10AA26CCB6594F9CD3E2A899preparation-assessments-v3.8.json
      /102/ten_point_assessment/current_manufacturer_labeling/title
      Historical; current review incomplete
      H51-65B19B4BF6B7CFBBCBA4D63Fpreparation-assessments-v3.8.json
      /102/ten_point_assessment/current_manufacturer_labeling/published_date
      Historical; current review incomplete
      H51-2BF4877E8CD43165901F27B5preparation-assessments-v3.8.json
      /102/ten_point_assessment/current_manufacturer_labeling/manufacturer
      Historical; current review incomplete
      H51-CEA9284C1F70A9B9D65E826Cpreparation-assessments-v3.8.json
      /102/ten_point_assessment/current_manufacturer_labeling/match_confidence
      Historical; current review incomplete
      H51-277BE49B2B47F3BCCB108BEFpreparation-assessments-v3.8.json
      /102/ten_point_assessment/current_manufacturer_labeling/url
      Historical; current review incomplete
      H51-209B823A6806B3A6D322F7CEpreparation-assessments-v3.8.json
      /102/field_provenance/exact_formulation/primary
      Historical; current review incomplete
      H51-D304F39CD298C32FA97ABE4Bpreparation-assessments-v3.8.json
      /102/field_provenance/reconstitution_concentration/primary
      Historical; current review incomplete
      H51-505C2C64583F282B725B5421preparation-assessments-v3.8.json
      /102/field_provenance/maximum_or_recommended_final_concentration/primary
      Historical; current review incomplete
      H51-AA1C1BD227483D8098D64C5Bpreparation-assessments-v3.8.json
      /102/field_provenance/appropriate_standardized_containers/primary
      Historical; current review incomplete
      H51-49E2B78774EDF041B8DC91B0preparation-assessments-v3.8.json
      /102/field_provenance/adult_dosing_range/primary
      Historical; current review incomplete
      H51-6C3530521C69B47E151E7531preparation-assessments-v3.8.json
      /102/field_provenance/pediatric_dosing_range/primary
      Historical; current review incomplete
      H51-B6741FABB33A478D1FFC7CD3preparation-assessments-v3.8.json
      /102/field_provenance/neonatal_dosing_range/primary
      Historical; current review incomplete
      H51-D5E935C50C47E13AF3F2EA7Apreparation-assessments-v3.8.json
      /102/field_provenance/infusion_time/primary
      Historical; current review incomplete
      H51-A09C9B2BF8E883D1583039D1preparation-assessments-v3.8.json
      /102/field_provenance/fluid_restriction_alternatives/primary
      Historical; current review incomplete
      H51-E9192FADD28C758F0CA654DBpreparation-assessments-v3.8.json
      /102/field_provenance/current_manufacturer_labeling/primary
      Historical; current review incomplete
      H51-9EA11DD59C29051B2AFD9B27preparation-assessments-v3.8.json
      /102/population_applicability/adult/applicability
      Historical; current review incomplete
      H51-CD92BFD854DA6FB89ADFB333preparation-assessments-v3.8.json
      /102/population_applicability/adult/guide_generation_allowed
      Historical; current review incomplete
      H51-6E475F68F4CB25A8E06A1ED2preparation-assessments-v3.8.json
      /102/population_applicability/pediatric/applicability
      Historical; current review incomplete
      H51-30AC23E8F69C3A156CC8EAFDpreparation-assessments-v3.8.json
      /102/population_applicability/pediatric/guide_generation_allowed
      Historical; current review incomplete
      H51-F716BEEAAD768DAFB84A0121preparation-assessments-v3.8.json
      /102/population_applicability/neonatal/applicability
      Historical; current review incomplete
      H51-9920C5AC571108CBD518951Cpreparation-assessments-v3.8.json
      /102/population_applicability/neonatal/guide_generation_allowed
      Historical; current review incomplete
      H51-411CB0F060E4CCC2CAB762A2preparation-assessments-v3.8.json
      /102/route_presence/structured_dilution
      Historical; current review incomplete
      H51-0F9C23754F088A5E692E152Dpreparation-assessments-v3.8.json
      /102/route_presence/iv_push
      Historical; current review incomplete
      H51-8D294A74F79AB8045B05AB6Apreparation-assessments-v3.8.json
      /102/route_presence/continuous_infusion
      Historical; current review incomplete
      H51-36494AC209A0353095F667FBpreparation-assessments-v3.8.json
      /102/route_presence/pediatric_source
      Historical; current review incomplete
      H51-7AC9DFD8D4F77484C93ABB14preparation-assessments-v3.8.json
      /102/route_presence/neonatal_source
      Historical; current review incomplete
      H51-631F5B2B25438E4BF4F40C97preparation-assessments-v3.8.json
      /102/legacy_reference/status
      Historical; current review incomplete
      H51-150D2D015270B65381A24968preparation-assessments-v3.8.json
      /102/label_resolution/status
      Historical; current review incomplete
      H51-476DF6039AD65D36FC6793F2preparation-assessments-v3.8.json
      /102/concentration_values_detected/0
      Historical; current review incomplete
      H51-FD17164F0E33D6B943647AB8preparation-assessments-v3.8.json
      /102/concentration_values_detected/0/low
      Historical; current review incomplete
      H51-427DDD207406CC9EC556ADD7preparation-assessments-v3.8.json
      /102/concentration_values_detected/0/high
      Historical; current review incomplete
      H51-053DAF8DEB55D8B61A0A9537preparation-assessments-v3.8.json
      /102/concentration_values_detected/0/unit
      Historical; current review incomplete
      H51-7F0D203345A8880CC836AEF9preparation-assessments-v3.8.json
      /102/concentration_values_detected/0/text
      Historical; current review incomplete
      H51-9F9CD996F4DBF7ADB139EFDBpreparation-assessments-v3.8.json
      /102/source_files/0
      Historical; current review incomplete
      H51-7F433287F946BC8BBB0BE76Cpreparation-assessments-v3.8.json
      /102/source_files/1
      Historical; current review incomplete
      H51-F493AC5F5A9288E9C4534B42preparation-assessments-v3.8.json
      /102/source_files/2
      Historical; current review incomplete
      H51-BD39F2F3F75B27B90871A5B0preparation-assessments-v3.8.json
      /102/clinical_release_note
      Historical; current review incomplete